Wells Fargo & Co. upgrades AmSurg shares — 5 notes

Wells Fargo & Co. boosted Nashville, Tenn.-base AmSurg’s rating from a “market perform” to an “outperform,” according to Daily Quint.

Advertisement

Here are five notes:

1. On Jan. 3, 2017, AmSurg shares opened the day trading at $66.82.

2. The company has a 52-week low is $57.75.

3. The 52-week high is $87.29.

4. AmSurg’s 50-day moving average price is $64.56 and its 200-day moving average price is $71.69.

5. The company’s market cap is $3.59 billion.

More articles on surgery centers:
Envision Healthcare Corp. expands in Arizona through Oro Valley Anesthesia acquisition: 4 highlights
Aurora Health Care to unveil ASC, hospital plans to community: 4 key points
25 statistics on EBITDA margins for ASCs

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in ASC Transactions & Valuation Issues

Advertisement

Comments are closed.